NCT05334875

Brief Summary

To assess repeatability of electroretinogram and visual evoked potential in clinical practice

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 7, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

April 19, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 30, 2022

Completed
Last Updated

April 19, 2022

Status Verified

April 1, 2022

Enrollment Period

7 months

First QC Date

April 7, 2022

Last Update Submit

April 13, 2022

Conditions

Keywords

ElectroretinogramVisual evoked potential

Outcome Measures

Primary Outcomes (1)

  • Repeatability of ERG amplitude.

    ERG amplitude measured in nano volt (nV).

    Changes from baseline measurements and at one week.

Secondary Outcomes (1)

  • Repeatability of ERG latency.

    Changes from baseline measurements and at one week.

Other Outcomes (2)

  • Repeatability of VEP amplitude.

    Changes from baseline measurements and at one week.

  • Repeatability of VEP latency.

    Changes from baseline measurements and at one week.

Study Arms (2)

Electroretinogram test (ERG)

ACTIVE COMPARATOR

ERG test will be done for each subject twice and compare the results to assess repeatability of the test.

Diagnostic Test: Electroretinogram (ERG)

Visual evoked potential test (VEP)

ACTIVE COMPARATOR

VEP test will be done for each subject twice and compare the results to assess repeatability of the test.

Diagnostic Test: Visual evoked potential (VEP)

Interventions

Applying electrodes to assess retinal function

Electroretinogram test (ERG)

Applying electrodes to assess visual pathway function

Visual evoked potential test (VEP)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normal subjects visit banha university hospital seeking regular checkup and subjects asked for ERG and VEP as a pre-occupational examination.

You may not qualify if:

  • Patients previously diagnosed with any retinal disease or visual pathway disease that may affect ERG and VEP tests.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ahmed Abdelshafy Tabl

Banhā, Benha, 13511, Egypt

RECRUITING

MeSH Terms

Conditions

Retinal DiseasesVision Disorders

Interventions

ElectroretinographyEvoked Potentials, Visual

Condition Hierarchy (Ancestors)

Eye DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Diagnostic Techniques, OphthalmologicalDiagnostic Techniques and ProceduresDiagnosisElectrodiagnosisEvoked PotentialsCortical ExcitabilityElectrophysiological PhenomenaPhysiological PhenomenaNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaOcular Physiological Phenomena

Study Officials

  • Ahmed A Abdelshafy, MD

    Benha University

    STUDY CHAIR

Central Study Contacts

Ahmed Abdelshafy, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Ophthalmology

Study Record Dates

First Submitted

April 7, 2022

First Posted

April 19, 2022

Study Start

April 1, 2022

Primary Completion

October 30, 2022

Study Completion

October 30, 2022

Last Updated

April 19, 2022

Record last verified: 2022-04

Locations